McGill University Health Centre (MUHC) news
New equipment gives neuro-surgeons unprecedented images of the brain and will also reduces wait times for children needing a standard MRI Scan
This statement provides a summary of the epidemiology of pandemic H1N1 human influenza (pH1N1), as well as information on the pH1N1 vaccine and its recommended usage.
Provides targeted information on the H1N1 Flu virus specifically for individuals with chronic medical conditions, including information on the H1N1 flu vaccine.
Describes what you need to know before receiving the H1N1 flu vaccine, including who should get it and when, how well the vaccine will protect against the H1N1 flu virus, how safe the vaccine is, risks from the H1N1 flu vaccine, and who should not get the H1N1 flu vaccine.
When considering your options about vaccination there are a number of factors that you should think about. This chart explains the risk of getting the flu versus the benefits and risks of getting an H1N1 flu vaccine and/or taking antiviral medication if you do get the flu.
Provides targeted information on the H1N1 Flu virus specifically for women who are pregnant or breastfeeding, including information on the H1N1 flu vaccine.
Provides targeted information on the H1N1 Flu virus specifically for children under the age of five, including information on the H1N1 flu vaccine.
Provides targeted information specifically for seniors on the topic of the seasonal and H1N1 flu viruses, including information on the seasonal flu vaccine and the H1N1 flu vaccine.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
NOTICE TO THE MEDIA - A tour of areas in the National Microbiology Laboratory that focus on work relating to the H1N1 flu virus.
Minister Aglukkaq, Dr. David-Butler-Jones and Dr. Danielle Grondin will provide a national update on the H1N1 flu virus.